5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.79▼ | 0.79▼ | 0.80▼ | 0.83▼ | 0.94▼ |
MA10 | 0.82▼ | 0.82▼ | 0.82▼ | 0.87▼ | 0.98▼ |
MA20 | 0.83▼ | 0.83▼ | 0.84▼ | 0.93▼ | 1.21▼ |
MA50 | 0.90▼ | 0.93▼ | 0.95▼ | 1.00▼ | N/A |
MA100 | 0.96▼ | 0.96▼ | 0.98▼ | 1.27▼ | N/A |
MA200 | 1.04▼ | 1.13▼ | 1.21▼ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.001▼ | -0.002▼ | -0.010▼ | N/A |
RSI | 35.184▼ | 35.516▼ | 36.141▼ | 35.053▼ | 36.005▼ |
STOCH | 20.053 | 19.864▼ | 17.352▼ | 18.627▼ | 13.879▼ |
WILL %R | -87.349▼ | -87.349▼ | -87.349▼ | -88.333▼ | -97.009▼ |
CCI | -104.537▼ | -105.364▼ | -122.557▼ | -112.449▼ | -110.498▼ |
Monday, April 28, 2025 05:00 AM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be ...
|
Sunday, April 27, 2025 10:00 PM
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical stage biopharmaceutical company, announces it will be presenting at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be ...
|
Thursday, April 24, 2025 12:15 PM
Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, issued a shareholder letter from CEO John Yu, M.D., outlining recen ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.80 | 0.84 | 0.785 | 0.785 | 60,300 |
30/04/25 | 0.84 | 0.851 | 0.75 | 0.811 | 116,800 |
28/04/25 | 0.867 | 0.867 | 0.827 | 0.842 | 36,400 |
25/04/25 | 0.8452 | 0.8799 | 0.84 | 0.867 | 49,876 |
24/04/25 | 0.87 | 0.88 | 0.821 | 0.853 | 127,300 |
23/04/25 | 0.881 | 0.8902 | 0.81 | 0.86 | 205,256 |
22/04/25 | 0.94 | 0.9426 | 0.8506 | 0.8948 | 136,077 |
21/04/25 | 0.95 | 0.9734 | 0.8786 | 0.9121 | 152,070 |
17/04/25 | 0.94 | 1.03 | 0.9264 | 0.96 | 316,530 |
16/04/25 | 1.04 | 1.04 | 0.884 | 0.907 | 108,500 |
|
|
||||
|
|
||||
|
|